(Q35587451)

9 August 2017

1 reference

title

Best Practice No 176: Updated recommendations for HER2 testing in the UK (English)

1 reference

9 August 2017

1 reference

A Rhodes

8

0 references

Sarah E. Pinder

7

object named as

S E Pinder

1 reference

9 August 2017

1

I O Ellis

1 reference

9 August 2017

J Bartlett

2

1 reference

9 August 2017

M Dowsett

3

1 reference

9 August 2017

S Humphreys

4

1 reference

9 August 2017

B Jasani

5

1 reference

9 August 2017

K Miller

6

1 reference

9 August 2017

R Walker

9

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Journal of Clinical Pathology

9 August 2017

published in

1 reference

9 August 2017

volume

57

1 reference

9 August 2017

issue

3

1 reference

9 August 2017

page(s)

233-237

1 reference

The clinical evaluation of HER-2 status: which test to use?

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770242

HER-2 in breast cancer--methods of detection, clinical significance and future prospects for treatment

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770242

Fluorescence in situ hybridization in paraffin tissue sections: pretreatment protocol

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770242

13. New biological therapies for breast cancer.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770242

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770242

A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770242

Breast cancer in the 21st century: neu opportunities and neu challenges

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770242

Recommendations for HER2 testing in the UK.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770242

The role of HER-2 expression in predicting response to therapy in breast cancer

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770242

Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770242

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770242

Evaluating HER2 amplification and overexpression in breast cancer.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770242

Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis

26 September 2018

1 reference

12 December 2020

The significance of histological determination of HER-2 status in breast cancer

1 reference

12 December 2020

Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries

1 reference

12 December 2020

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

1 reference

12 December 2020

Identifiers

DOI

10.1136/JCP.2003.007724

1 reference

9 August 2017

1 reference

9 August 2017

1 reference